Application of SDC1 as drug treatment target for bone destruction diseases

The invention provides application of SDC1 as a drug treatment target for bone destruction diseases, and relates to the technical field of biological medicines. The invention also provides an application of the SDC1 inhibitor in preparation of drugs for treating bone destruction diseases, the SDC1 i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHENG JIEHUANG, WANG YIYUAN, CHEN YAN, LI XIAOJUAN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHENG JIEHUANG
WANG YIYUAN
CHEN YAN
LI XIAOJUAN
description The invention provides application of SDC1 as a drug treatment target for bone destruction diseases, and relates to the technical field of biological medicines. The invention also provides an application of the SDC1 inhibitor in preparation of drugs for treating bone destruction diseases, the SDC1 inhibitor is siRNA or monoclonal antibody of SDC1, and the siRNA or monoclonal antibody of the SDC1 inhibitor can be used for preparing drugs for treating bone destruction diseases. 本发明提供一种SDC1作为骨质破坏疾病药物治疗靶点的应用,涉及生物医药技术领域。本发明还提供一种SDC1抑制剂在制备治疗骨质破坏疾病药物中的应用,SDC1抑制剂为SDC1的siRNA或单克隆抗体,SDC1抑制剂siRNA或单克隆抗体可用于制备治疗骨质破坏疾病的药物。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115120725A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115120725A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115120725A3</originalsourceid><addsrcrecordid>eNqNyzEKAjEQRuE0FqLeYTyAYFYW6yUqYmGj_TImf5aFNQmZ2fsL4gGsXvO9pbl1pUyjZx1zohzpcXKWWCjUeSCtYH0jKSnXAUoxV3rlBAoQrbP_XmEUsEDWZhF5Emx-XZnt5fx01x1K7iGFPRK0d3drW9vsj03bHf4xH8tSNIY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of SDC1 as drug treatment target for bone destruction diseases</title><source>esp@cenet</source><creator>ZHENG JIEHUANG ; WANG YIYUAN ; CHEN YAN ; LI XIAOJUAN</creator><creatorcontrib>ZHENG JIEHUANG ; WANG YIYUAN ; CHEN YAN ; LI XIAOJUAN</creatorcontrib><description>The invention provides application of SDC1 as a drug treatment target for bone destruction diseases, and relates to the technical field of biological medicines. The invention also provides an application of the SDC1 inhibitor in preparation of drugs for treating bone destruction diseases, the SDC1 inhibitor is siRNA or monoclonal antibody of SDC1, and the siRNA or monoclonal antibody of the SDC1 inhibitor can be used for preparing drugs for treating bone destruction diseases. 本发明提供一种SDC1作为骨质破坏疾病药物治疗靶点的应用,涉及生物医药技术领域。本发明还提供一种SDC1抑制剂在制备治疗骨质破坏疾病药物中的应用,SDC1抑制剂为SDC1的siRNA或单克隆抗体,SDC1抑制剂siRNA或单克隆抗体可用于制备治疗骨质破坏疾病的药物。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220930&amp;DB=EPODOC&amp;CC=CN&amp;NR=115120725A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220930&amp;DB=EPODOC&amp;CC=CN&amp;NR=115120725A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHENG JIEHUANG</creatorcontrib><creatorcontrib>WANG YIYUAN</creatorcontrib><creatorcontrib>CHEN YAN</creatorcontrib><creatorcontrib>LI XIAOJUAN</creatorcontrib><title>Application of SDC1 as drug treatment target for bone destruction diseases</title><description>The invention provides application of SDC1 as a drug treatment target for bone destruction diseases, and relates to the technical field of biological medicines. The invention also provides an application of the SDC1 inhibitor in preparation of drugs for treating bone destruction diseases, the SDC1 inhibitor is siRNA or monoclonal antibody of SDC1, and the siRNA or monoclonal antibody of the SDC1 inhibitor can be used for preparing drugs for treating bone destruction diseases. 本发明提供一种SDC1作为骨质破坏疾病药物治疗靶点的应用,涉及生物医药技术领域。本发明还提供一种SDC1抑制剂在制备治疗骨质破坏疾病药物中的应用,SDC1抑制剂为SDC1的siRNA或单克隆抗体,SDC1抑制剂siRNA或单克隆抗体可用于制备治疗骨质破坏疾病的药物。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyzEKAjEQRuE0FqLeYTyAYFYW6yUqYmGj_TImf5aFNQmZ2fsL4gGsXvO9pbl1pUyjZx1zohzpcXKWWCjUeSCtYH0jKSnXAUoxV3rlBAoQrbP_XmEUsEDWZhF5Emx-XZnt5fx01x1K7iGFPRK0d3drW9vsj03bHf4xH8tSNIY</recordid><startdate>20220930</startdate><enddate>20220930</enddate><creator>ZHENG JIEHUANG</creator><creator>WANG YIYUAN</creator><creator>CHEN YAN</creator><creator>LI XIAOJUAN</creator><scope>EVB</scope></search><sort><creationdate>20220930</creationdate><title>Application of SDC1 as drug treatment target for bone destruction diseases</title><author>ZHENG JIEHUANG ; WANG YIYUAN ; CHEN YAN ; LI XIAOJUAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115120725A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHENG JIEHUANG</creatorcontrib><creatorcontrib>WANG YIYUAN</creatorcontrib><creatorcontrib>CHEN YAN</creatorcontrib><creatorcontrib>LI XIAOJUAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHENG JIEHUANG</au><au>WANG YIYUAN</au><au>CHEN YAN</au><au>LI XIAOJUAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of SDC1 as drug treatment target for bone destruction diseases</title><date>2022-09-30</date><risdate>2022</risdate><abstract>The invention provides application of SDC1 as a drug treatment target for bone destruction diseases, and relates to the technical field of biological medicines. The invention also provides an application of the SDC1 inhibitor in preparation of drugs for treating bone destruction diseases, the SDC1 inhibitor is siRNA or monoclonal antibody of SDC1, and the siRNA or monoclonal antibody of the SDC1 inhibitor can be used for preparing drugs for treating bone destruction diseases. 本发明提供一种SDC1作为骨质破坏疾病药物治疗靶点的应用,涉及生物医药技术领域。本发明还提供一种SDC1抑制剂在制备治疗骨质破坏疾病药物中的应用,SDC1抑制剂为SDC1的siRNA或单克隆抗体,SDC1抑制剂siRNA或单克隆抗体可用于制备治疗骨质破坏疾病的药物。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN115120725A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Application of SDC1 as drug treatment target for bone destruction diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A38%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHENG%20JIEHUANG&rft.date=2022-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115120725A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true